CompoAtlas

Alfalfa Complex

Natural health product licensed in Canada

Licence holder
Shaklee Canada Inc.
NPN or DIN-HM
80090650
Status
Active licence
Licence date
17 February 2019
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Medicago sativa

Source : Sommité

300 milligrammeNot calculated
Calcium

Source : Phosphate de calcium, tribasique

30 milligramme900,000 µg
Calcium

Source : Silicate de calcium

30 milligramme900,000 µg
Calcium

Source : Phosphate de calcium, dibasique, dihydraté

30 milligramme900,000 µg
Phosphore

Source : Phosphate de calcium, dibasique, dihydraté

23.3 milligramme699,000 µg
Phosphore

Source : Phosphate de calcium, tribasique

23.3 milligramme699,000 µg
Silicium

Source : Silicate de calcium

1.5 milligrammeNot calculated

Non-medicinal ingredients

Essence de Menthe verte, D-Fructose, Maltodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years10 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Medicago sativa (Alfalfa) is traditionally used in herbal medicine as a nutritive tonic. Helps support bone health. Helps maintain muscle function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80090650

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line